Pluristem's PLX cells perform well in tendon injures in rats

|About: Pluristem Therapeutics, Inc. (PSTI)|By:, SA News Editor

Pluristem's (PSTI +2%) PLacental eXpanded (PLX) cells produce positive results in pre-clinical trials of rats with tendon injuries.

"PLX-treated tendons demonstrated better early structural properties at two and four weeks compared to saline-treated controls," Pluristem says.

"As an 'off the shelf' cell source, PLX cells could provide an effective option to improve tendon healing," says Dr Scott Rodeo, the Principal Investigator for the study.

PLX is undergoing a Phase I/II clinical trial in Germany to test it in muscle injuries. (PR)